1) Haploidentical
HLA半相合
1.
Preliminary Observation on Antitumor Effect of IL-2 Activated HLA Haploidentical Allogenic Peripheral Blood Monocular Cells in Treatment of Metastatic or Chemo-resistant Solid Tumor;
IL-2短期活化的HLA半相合的外周血单个核细胞治疗晚期恶性实体瘤初步观察
2.
Part I: Observation on antitumor effect of mobilizing activated related HLA-haploidentical allogenic mononuclear cells in treatment of the metastatic or chemoresistant solid tumor patientsobjective To study the feasibility of activated related HLA-haploidentical allogenic monocytes in treatment of the metastatic or chemoresistant solid tumor patients.
第—部分:活化动员的亲缘间HLA半相合异基因单个核细胞治疗晚期转移或化疗抵抗性 实体瘤初步观察 目的:初步探讨活化动员的亲缘间HLA半相合异基因单个核细胞治疗晚期转移性/化疗抗性实体瘤的可行性。
2) HLA haploidentical
HLA半相合
1.
Clinical study on transplantation of HLA haploidentical stem cell for the treatment of leukemia
亲缘HLA半相合造血干细胞移植治疗白血病10例临床分析
2.
Objective:To study the antineoplasmic activity and mechanism of action of activated HLA haploidentical peripheral blood stem cells in vivo and in vitro,and further study the safety and feasibility in treatment of advanced intractable solid tumor patients.
目的:初步探讨活化的HLA半相合外周血干细胞(haplo-PBSCs)在体内外的抗肿瘤活性和作用机制,评价其治疗晚期难治性实体瘤的安全性和可行性,并分析影响其治疗效果的相关因素,以期为晚期难治性实体瘤患者提供一条新的安全的异体免疫治疗途径。
3) HLA-haploidenti-cal transplantation
HLA-半相合
4) HLA mismatch
HLA不相合
1.
Objective: To explore the feasibility of HLA mismatched hemopietic stem cell transplants for the treatment of leukemia.
方法 :总结我所于 2 0 0 0年 7月至 2 0 0 1年 12月进行的 7例HLA不相合造血干细胞移植 ,其中包括 3例慢性髓性白血病、3例急性非淋巴细胞性白血病、1例急性淋巴细胞白血病。
5) HLA matched
HLA全相合
1.
24 patients with various hematologic malignancies recieved PBSCT/BMT from their HLA matched or unrelated donors and haploidentical siblings in April-December 2007.
24例不同血液病患者接受HLA全相合同胞、非血缘供者或单倍体相合同胞造血干细胞移植。
6) HLA non-identical
HLA不全相合
1.
HLA non-identical allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia;
HLA不全相合异基因外周血干细胞移植治疗重型再生障碍性贫血
补充资料：HLA
分子式：
CAS号：
性质：一个复杂的抗原群，决定了人类组织的组织配伍性，正如ABO血型抗原决定了输血的配伍性一样。
CAS号：
性质：一个复杂的抗原群，决定了人类组织的组织配伍性，正如ABO血型抗原决定了输血的配伍性一样。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条